Pu L, Beale O, Meng X
Bioengineering (Basel). 2025; 12(2).
PMID: 40001677
PMC: 11852169.
DOI: 10.3390/bioengineering12020157.
Abramoff M, Lavin P, Jakubowski J, Blodi B, Keeys M, Joyce C
NPJ Digit Med. 2024; 7(1):369.
PMID: 39702673
PMC: 11659561.
DOI: 10.1038/s41746-024-01389-x.
Tesfaye H, Paik J, Roh M, Htoo P, Zakoul H, Schmedt N
JAMA Ophthalmol. 2024; 143(1):62-71.
PMID: 39636645
PMC: 11622102.
DOI: 10.1001/jamaophthalmol.2024.5219.
Rojekar S, Parit S, Gholap A, Manchare A, Nangare S, Hatvate N
Pharmaceutics. 2024; 16(11).
PMID: 39598522
PMC: 11597228.
DOI: 10.3390/pharmaceutics16111398.
Luo J, Yu F, Zhou H, Wu X, Zhou Q, Liu Q
Medicine (Baltimore). 2024; 103(26):e38583.
PMID: 38941365
PMC: 11466165.
DOI: 10.1097/MD.0000000000038583.
Factors associated with development of retinopathy in patients with type 2 diabetes mellitus at onset and within three years after diagnosis.
Andersson K, Halling A, Agvall B
Scand J Prim Health Care. 2024; 42(3):408-414.
PMID: 38647202
PMC: 11332278.
DOI: 10.1080/02813432.2024.2329215.
Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review.
Gholami Chahkand M, Esmaeilpour Moallem F, Qezelgachi A, Seifouri K, Pesaran Afsharian A, Sheikhzadeh F
Diab Vasc Dis Res. 2023; 20(6):14791641231197114.
PMID: 38018132
PMC: 10685788.
DOI: 10.1177/14791641231197114.
Risk Factors for Nondiagnostic Imaging in a Real-World Deployment of Artificial Intelligence Diabetic Retinal Examinations in an Integrated Healthcare System: Maximizing Workflow Efficiency Through Predictive Dilation.
Shou B, Venkatesh K, Chen C, Ghidey R, Lee J, Wang J
J Diabetes Sci Technol. 2023; 18(2):302-308.
PMID: 37798955
PMC: 10973867.
DOI: 10.1177/19322968231201654.
Prevalence and Visual Consequences of Non-adherent Patients Receiving Anti-vascular Endothelial Growth Factor (VEGF) Injections at King Fahad Specialist Hospital (KFSH), Qassim Region.
Alharbi A, Alotayk N, Alaboudi A, Alammar A, Aldekhail M, Alharbi M
Cureus. 2023; 15(8):e44340.
PMID: 37779785
PMC: 10538945.
DOI: 10.7759/cureus.44340.
Immune Fingerprint in Diabetes: Ocular Surface and Retinal Inflammation.
Amorim M, Martins B, Fernandes R
Int J Mol Sci. 2023; 24(12).
PMID: 37372968
PMC: 10298084.
DOI: 10.3390/ijms24129821.
Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm.
Tarasewicz D, Karter A, Pimentel N, Moffet H, Thai K, Schlessinger D
Diabetes Care. 2023; 46(5):1068-1075.
PMID: 36930723
PMC: 10257789.
DOI: 10.2337/dc22-1168.
Advanced Glycation End-Products and Diabetic Neuropathy of the Retina.
Oshitari T
Int J Mol Sci. 2023; 24(3).
PMID: 36769249
PMC: 9917392.
DOI: 10.3390/ijms24032927.
A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy.
Yoo S, You D, Lee J, Hong H, Lee S
Medicina (Kaunas). 2023; 59(1).
PMID: 36676801
PMC: 9862301.
DOI: 10.3390/medicina59010178.
Dehydrozingerone promotes healing of diabetic foot ulcers: a molecular insight.
Begum F, Manandhar S, Kumar G, Keni R, Sankhe R, Gurram P
J Cell Commun Signal. 2022; 17(3):673-688.
PMID: 36280629
PMC: 10409929.
DOI: 10.1007/s12079-022-00703-0.
Efficacy of smartphone-based retinal photography by undergraduate students in screening and early diagnosing diabetic retinopathy.
Gobbi J, Braga J, Lucena M, Bellanda V, Frasson M, Ferraz D
Int J Retina Vitreous. 2022; 8(1):35.
PMID: 35672839
PMC: 9172171.
DOI: 10.1186/s40942-022-00388-y.
Association of retinopathy severity with cardiovascular and renal outcomes in patients with type 1 diabetes: a multi-state modeling analysis.
Wang W, Ou H, Wen M, Su P, Yang C, Kuo T
Sci Rep. 2022; 12(1):4177.
PMID: 35264740
PMC: 8907198.
DOI: 10.1038/s41598-022-08166-4.
A Classification Tree Model with Optical Coherence Tomography Angiography Variables to Screen Early-Stage Diabetic Retinopathy in Diabetic Patients.
Yao H, Wu S, Zhan Z, Li Z
J Ophthalmol. 2022; 2022:9681034.
PMID: 35211344
PMC: 8863461.
DOI: 10.1155/2022/9681034.
Effect of diabetes blood-stasis syndrome and Xuefu Zhuyu decoction on ERK1/2-VEGF signal pathway in rat retina Müller cells.
Ye X, Ren H, Jiang T, Zhang T, Li G
Histol Histopathol. 2022; 37(8):757-767.
PMID: 35112334
DOI: 10.14670/HH-18-427.
Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital-Based Study.
Ezhilvendhan K, Sathiyamoorthy A, Prakash B, Bhava B, Shenoy A
J Pharm Bioallied Sci. 2022; 13(Suppl 2):S1062-S1067.
PMID: 35017930
PMC: 8686907.
DOI: 10.4103/jpbs.jpbs_164_21.
Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy.
Oshitari T
Int J Environ Res Public Health. 2022; 19(1).
PMID: 35010703
PMC: 8744686.
DOI: 10.3390/ijerph19010439.
